Physician profile
Sheriff Dodoo
NPI 1578981882
$4,736.57
in general payments reported to CMS, 2019-2025
18 companies · $2,507 in 2025
The $2,507 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.65 · 2021: $34.14 · 2022: $140 · 2023: $393 · 2024: $1,638 · 2025: $2,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,141 · Travel and Lodging: $1,591 · Education: $472 · Grant: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,141.14 |
| Travel and Lodging | $1,590.74 |
| Education | $472.25 |
| Grant | $333.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,381.87 | 2024-2025 | General - Therapies, General - Vascular Access, Avvigo Guidance System |
| Zoll Circulation INC | $1,077.33 | 2024 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Abbott Laboratories | $518.22 | 2022-2025 | Ensite, Esprit |
| Abiomed | $472.12 | 2023-2025 | Impella |
| Philips North America LLC | $463.43 | 2025 | Igt Devices Undivided |
| Penumbra, INC. | $189.00 | 2025 | Indigo System, Penumbra System |
| Regeneron Healthcare Solutions, INC. | $118.44 | 2022 | |
| Teleflex LLC | $113.11 | 2025 | Trapliner |
| Alnylam Pharmaceuticals INC. | $97.24 | 2025 | Amvuttra |
| Actelion Pharmaceuticals US, INC. | $89.00 | 2024 | Uptravi, Opsumit |
| Sanofi-Aventis U.S. LLC | $63.94 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.29 | 2023-2024 | Lifevest |
| Pfizer INC. | $34.14 | 2021 | |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Astrazeneca Pharmaceuticals LP | $16.22 | 2024 | Farxiga |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $13.95 | 2024 | |
| Novartis Pharmaceuticals Corporation | $12.63 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheriff Dodoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.